Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details)

v3.24.1.u1
Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities (in shares) 2,570 2,537
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities (in shares) 197 268
Restricted Stock [Member]    
Antidilutive Securities (in shares) 1,133 1,029
Warrant [Member]    
Antidilutive Securities (in shares) 1,240 1,240